Controlled Release of Doxorubicin for Targeted Chemo-Photothermal Therapy in Breast Cancer HS578T Cells Using Albumin Modified Hybrid Nanocarriers

Controlled Release of Doxorubicin for Targeted Chemo-Photothermal Therapy in Breast Cancer HS578T Cells Using Albumin Modified Hybrid Nanocarriers

Hybrid nanomaterials have attracted research interest owing to their intriguing properties, which may offer new diagnostic options with triggering features, able to realize a new kind of tunable nanotherapeutics. Hybrid silica/melanin nanoparticles (NPs) containing silver seeds (Me-laSil_Ag-HSA NPs)...

Full description

Bibliographic Details
Main Authors: Barbara Carrese, Chiara Cavallini, Gennaro Sanità, Paolo Armanetti, Brigida Silvestri, Gaetano Calì, Giulio Pota, Giuseppina Luciani, Luca Menichetti, Annalisa Lamberti
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
doxorubicin
photothermal
breast cancer
PTT
hybrid nanoparticles
melanin nanoparticles
Online Access:https://www.mdpi.com/1422-0067/22/20/11228

Internet

https://www.mdpi.com/1422-0067/22/20/11228

Similar Items